Oscar Health, Inc. $OSCR Shares Sold by State of Wyoming

State of Wyoming trimmed its holdings in Oscar Health, Inc. (NYSE:OSCR) by 57.3% in the third quarter, Holdings Channel.com reports. The institutional investor owned 14,018 shares of the company’s stock after selling 18,820 shares during the quarter. State of Wyoming’s holdings in Oscar Health were worth $432,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the business. Tidal Investments LLC purchased a new position in Oscar Health in the 2nd quarter worth approximately $2,240,000. Convergence Investment Partners LLC purchased a new stake in shares of Oscar Health in the first quarter valued at approximately $1,208,000. Genesee Capital Advisors LLC grew its position in shares of Oscar Health by 227.8% in the third quarter. Genesee Capital Advisors LLC now owns 44,338 shares of the company’s stock valued at $1,367,000 after purchasing an additional 30,814 shares in the last quarter. Wellington Management Group LLP increased its holdings in shares of Oscar Health by 65.6% in the second quarter. Wellington Management Group LLP now owns 603,675 shares of the company’s stock valued at $17,217,000 after purchasing an additional 239,109 shares during the last quarter. Finally, AXQ Capital LP acquired a new stake in shares of Oscar Health in the second quarter valued at approximately $1,059,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Oscar Health Stock Up 4.5%

Shares of NYSE OSCR opened at $32.38 on Wednesday. The company has a market capitalization of $9.99 billion, a P/E ratio of 23.13, a P/E/G ratio of 0.34 and a beta of 2.56. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.09 and a quick ratio of 1.09. The company has a 50 day simple moving average of $31.68 and a 200-day simple moving average of $23.72. Oscar Health, Inc. has a 1 year low of $10.69 and a 1 year high of $35.01.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Thursday, August 6th. The company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.70. The firm had revenue of $4.88 billion for the quarter, compared to analysts’ expectations of $4.73 billion. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%. The firm’s quarterly revenue was up 70.4% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.89) earnings per share. On average, equities research analysts predict that Oscar Health, Inc. will post 1.83 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have weighed in on OSCR. Robert W. Baird boosted their price objective on Oscar Health from $27.00 to $33.00 and gave the stock a “neutral” rating in a research note on Thursday, September 17th. Barclays raised their target price on Oscar Health from $39.00 to $49.00 and gave the stock an “overweight” rating in a research note on Thursday, September 17th. Weiss Ratings upgraded Oscar Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Stephens reissued an “equal weight” rating and set a $34.00 price target on shares of Oscar Health in a research report on Thursday, September 17th. Finally, Piper Sandler reissued an “overweight” rating and set a $48.00 price target on shares of Oscar Health in a research report on Thursday, September 17th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $34.90.

Insider Buying and Selling

In other news, Director Mario Schlosser sold 31,422 shares of the stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total transaction of $988,221.90. Following the completion of the transaction, the director directly owned 449,444 shares in the company, valued at approximately $14,135,013.80. This represents a 6.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Vanessa Wittman sold 25,000 shares of the firm’s stock in a transaction dated Friday, September 18th. The stock was sold at an average price of $32.24, for a total value of $806,000.00. Following the sale, the director directly owned 112,121 shares of the company’s stock, valued at $3,614,781.04. The trade was a 18.23% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 874,451 shares of company stock valued at $26,761,671. 22.64% of the stock is currently owned by company insiders.

About Oscar Health

Oscar Health, Inc is a technology-focused health insurance company that provides health plans and related services in the United States. The company primarily serves individuals and families purchasing coverage through the Affordable Care Act’s health insurance marketplace, as well as small businesses and their employees.

Oscar combines health insurance products with digital tools designed to help members manage their care. Its services include online enrollment, virtual care, provider search and appointment support, care navigation, claims and benefits information, and member engagement through web and mobile applications.